Drug Screening Market Insights
North America and Europe are
expected to Dominate
the Drug Screening Market over the forecast period due to presence of
leading manufacturers such as Alere, Inc. Mergers and acquisitions by key
players are expected to foster growth of the market such as Abbott Laboratories
acquisition of Alere, Inc. in 2017. Asia Pacific region is expected to witness
significant growth over the forecast period, owing to increasing presence of
leading manufacturers in the region. For instance, Alere Medical Pvt. Ltd.
launched integrated facility in India for manufacturing rapid point of care
diagnostic devices in 2016. The company intends to make India an export hub for
rapid diagnostic devices in Asia Pacific region.
Drug screening involves testing
of the samples such as urine, breath, oral fluid, hair, and others for presence
of any substances over the limit. The significance of the drug screening is
that a person under influence of the drugs or alcohol is liable for road
accidents, and other workplace issues. Manufacturers such as Abbott
Laboratories provide drug screening tests for testing purposes at workplace, in
government organizations, rehabilitation centers, and other places. These tests
are painless and non-invasive. Moreover, manufacturers such as Alere, Inc.
(part of Abbott Laboratories) provide point-of-care diagnostic tests for drug
screening. Furthermore, drug addict individuals involved in certain professions
such as an air traffic controller, and commercial drivers can risk safety of
others, which can be avoided by pre-employment urine testing. On-the-job
accidents could also be reduced with the help of drug screening. A urine drug
test is painless and analyzes presence of prescription drugs such as
amphetamines, methamphetamines, benzodiazepines, marijuana, barbiturates,
cocaine, methadone, and opioids (narcotics). Moreover, drug and alcohol
rehabilitation centers need to test residents on a regular basis to ensure the
soberness of the people receiving treatment. Oral fluid testing and breath
testing is conducted to examine presence of alcohol in the body and to ascertain
the level of the same. Technological advancements such as immunoassay
techniques for drug screening, and rapid point of care tests have fostered
growth of the drug screening market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1696
Drug Screening Market Drivers
Competition among leading
manufacturers in the drug screening market is supporting the growth of the drug
screening market. Manufacturers are engaged in developing innovative products
in wide categories in order to maintain leading position in the market. Alere,
Inc. along with its partner company GenPrime, Inc., launched point of care
testing device, the xReader for work-place drug testing in 2016. In 2017,
Alere, Inc. launched Alere iCup Rx drug screen for detecting commonly misused
and abused prescription drugs. Moreover, technological advancements are
expected to boost growth of the drug screening market over the forecast period.
For instance, Intelligent Fingerprinting Limited launched non-invasive portable
fingerprint drug test in 2017. Moreover, increasing incidences of traffic
accidents, owing to drunk driving or driving after drug consumption is expected
to boost growth of the drug screening market over the forecast period. For
instance, five Michigan counties launched pilot roadside drug testing in November
2017, which used Alere DDS2 oral fluid test instrument to detect marijuana,
opioids, and other drugs. Moreover, Captiva Lab launched an oral fluid drug
testing integrated with mass spectrometry to include an oral fluid test panel
in 2017. Furthermore, increasing demand from vast number of places where drug
screening may be required such as workplace, hospitals, and rehabilitation
centers is expected to boost growth of the drug screening market over the
forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/drug-screening-market-1696
Phenomenex, Inc. launched Strata-X-Drug
B Plus a solid phase extraction (SPE) sample preparation product for urine drug
testing in May 2018.
However, ban of alcohol and drugs
at workplace and government organizations, and increasing awareness against
driving under influence is expected to hinder the growth of the drug screening
market.
Drug Screening Market Competitive
Landscape
Key players operating in the
global drug screening market include Thermo Fisher Scientific, Quest
Diagnostics, Omega Laboratories, Abbott Laboratories, Danaher Corporation,
Express Diagnostics International Inc., Siemens Healthineers, Alfa Scientific
Designs, F. Hoffmann La Roche, SureHire, and OraSure.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1696
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200 Seattle,
WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment